{"organizations": [], "uuid": "c426d90fe3f8f85aa841b847a23131647962030a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pernix-therapeutics-expects-to-res/brief-pernix-therapeutics-expects-to-resume-distribution-of-20-mg-dosage-strength-of-zohydro-er-with-beadtek-idUSFWN1R90DB", "country": "US", "domain_rank": 408, "title": "BRIEF-Pernix Therapeutics - Expects To Resume Distribution Of 20 Mg Dosage Strength Of Zohydro ER With Beadtek", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-27T15:08:00.000+03:00", "replies_count": 0, "uuid": "c426d90fe3f8f85aa841b847a23131647962030a"}, "author": "", "url": "https://www.reuters.com/article/brief-pernix-therapeutics-expects-to-res/brief-pernix-therapeutics-expects-to-resume-distribution-of-20-mg-dosage-strength-of-zohydro-er-with-beadtek-idUSFWN1R90DB", "ord_in_thread": 0, "title": "BRIEF-Pernix Therapeutics - Expects To Resume Distribution Of 20 Mg Dosage Strength Of Zohydro ER With Beadtek", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "pernix therapeutics holdings inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "dosage strength of zohydro er with beadtek reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 09 PM / Updated 22 minutes ago BRIEF-Pernix Therapeutics - Expects To Resume Distribution Of 20 Mg Dosage Strength Of Zohydro ER With Beadtek Reuters Staff 1 Min Read March 27 (Reuters) - Pernix Therapeutics Holdings Inc : * PERNIX THERAPEUTICS HOLDINGS - EXPECTS TO RESUME DISTRIBUTION OF 20 MG DOSAGE STRENGTH OF ZOHYDRO ER (HYDROCODONE BITARTRATE) WITH BEADTEK ON MARCH 28 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-03-27T15:08:00.000+03:00", "crawled": "2018-03-27T15:36:05.008+03:00", "highlightTitle": ""}